BiotechTube
Home/Pipeline/RECCE® 435

RECCE® 435

Oral broad‑spectrum antibacterial

PreclinicalActive

Key Facts

Indication
Oral broad‑spectrum antibacterial
Phase
Preclinical
Status
Active
Company
Recce Pharmaceuticals

About Recce Pharmaceuticals

Recce creates synthetic polymer anti‑infectives to combat multidrug‑resistant bacteria and viruses.

View full company profile

Therapeutic Areas

AntibacterialAntiviralInfectious Diseases